Treatment

Hydagelan 20 mg/ml Injektions-/Infusionslösung clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
Pilot study on the safety and feasibility of intravenous opioid agonist therapy (OAT) with Hydagelan® (hydromorphone hydrochloride) in Vienna.
This study in Vienna is looking at a new treatment called Hydagelan to help people with opioid dependence. It's testing if giving this medicine through a drip is safe and practical, and if it helps people use fewer illegal opioids.
For: Opioid dependence: Opioid dependence is a serious and usually chronic disease that requires treatment · encompasses various psychological and physical dimensions · and is associated with concomitant diseases and increased mortality.
Austria